These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 28722500)

  • 1. Post-marketing surveillance study of the long-term use of mizoribine for the treatment of lupus nephritis: 2-Year results.
    Takeuchi T; Okada K; Yoshida H; Yagi N
    Mod Rheumatol; 2018 Jan; 28(1):85-94. PubMed ID: 28722500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of multitarget therapy with mizoribine and tacrolimus for systemic lupus erythematosus with or without active nephritis.
    Nomura A; Shimizu H; Kishimoto M; Suyama Y; Rokutanda R; Ohara Y; Yamaguchi K; Okada M
    Lupus; 2012 Nov; 21(13):1444-9. PubMed ID: 22917589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first year results of mizoribine/tacrolimus-based multitarget treatment for consecutive patients with lupus nephritis.
    Kagawa H; Hiromasa T; Yamanaka R; Hayashi R; Tsunashima Y; Inoue T; Sada KE
    Clin Exp Nephrol; 2018 Dec; 22(6):1371-1378. PubMed ID: 29948442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mizoribine, tacrolimus, and corticosteroid combination therapy successfully induces remission in patients with lupus nephritis.
    Kagawa H; Hiromasa T; Hara T; Takaki A; Yamanaka R; Sada KE; Makino H
    Clin Exp Nephrol; 2012 Oct; 16(5):760-6. PubMed ID: 22492013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H; Aizawa T; Watanabe S; Oki E; Tsuruga K; Imaizumi T
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term treatment with mizoribine in patients with proliferative lupus nephritis.
    Yumura W; Suganuma S; Uchida K; Moriyama T; Otsubo S; Takei T; Naito M; Koike M; Nitta K; Nihei H
    Clin Nephrol; 2005 Jul; 64(1):28-34. PubMed ID: 16047642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H; Tsugawa K; Suzuki K; Nakahata T; Ito E
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose tacrolimus in treating lupus nephritis refractory to cyclophosphamide: a prospective cohort study.
    Fei Y; Wu Q; Zhang W; Chen H; Hou Y; Xu D; Li M; Zhang X; Zhao Y; Zeng X; Zhang F
    Clin Exp Rheumatol; 2013; 31(1):62-8. PubMed ID: 22935463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of weekly mizoribine pulse therapy in refractory lupus nephritis.
    Nishi E; Kameda H; Ogawa H; Nagasawa H; Takei H; Okuyama A; Kurasawa T; Kondo T; Nishimura K; Shirai Y; Sakai R; Ito T; Takeuchi T; Amano K
    Mod Rheumatol; 2013 Jan; 23(1):97-103. PubMed ID: 22526831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Safety and Effectiveness of Tacrolimus in Patients With Lupus Nephritis in Japan: 10-Year Analysis of the Real-World TRUST Study.
    Takeuchi T; Wakasugi N; Hashida T; Uno S; Makino H
    J Rheumatol; 2024 Jun; 51(6):613-621. PubMed ID: 38359944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of tacrolimus for maintenance therapy of lupus nephritis: a 5-year retrospective study at a single center.
    Karasawa K; Uchida K; Kodama M; Moriyama T; Nitta K
    Rheumatol Int; 2018 Dec; 38(12):2271-2277. PubMed ID: 30203113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H; Watanabe S; Aizawa-Yashiro T; Oki E; Kumagai N; Tsuruga K; Ito E
    Nephron Clin Pract; 2012; 121(3-4):c165-73. PubMed ID: 23327881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of class IV+V lupus nephritis with combination therapy of high-dose corticosteroids, tacrolimus and intravenous cyclophosphamide.
    Kurasawa T; Nagasawa H; Nishi E; Takei H; Okuyama A; Kondo T; Nishimura K; Sakai R; Shibata A; Chino K; Ogawa H; Ito T; Amano K; Kato H
    Intern Med; 2013; 52(10):1125-30. PubMed ID: 23676603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus use and renal function in pregnancy with lupus nephritis: Analysis of post-marketing surveillance data in Japan.
    Suzuki K; Uno S; Wakasugi N
    Mod Rheumatol; 2023 Aug; 33(5):944-952. PubMed ID: 35982545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mizoribine versus mycophenolate mofetil or intravenous cyclophosphamide for induction treatment of active lupus nephritis.
    Feng X; Gu F; Chen W; Liu Y; Wei H; Liu L; Yin S; Da Z; Sun L
    Chin Med J (Engl); 2014; 127(21):3718-23. PubMed ID: 25382325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the efficacy of mizoribine in lupus nephritis in Chinese patients.
    Zhang M; Xing CY; Liu J
    Rheumatol Int; 2013 Nov; 33(11):2737-42. PubMed ID: 23797779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
    Mok CC; Tong KH; To CH; Siu YP; Au TC
    Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.